
LifeWave provides a non-invasive monitoring system that measures lung fluid to help manage heart failure at home and in clinic. The company combines a medical radar lung sensor built on ultra-wideband radio frequency (UWB/RF) with an AI-powered CardioConnect platform to deliver an objective biomarker for lung fluid and support Guideline Directed Medical Therapy (GDMT) optimization. CardioConnect is offered as a SaaS solution that integrates clinician workflows and patient self-management, and the sensing hardware is intended for simple, low-cost home use. LifeWave holds issued and pending patents around its UWB/RF physiologic assessment technology and targets homecare programs, clinicians, and heart failure patients.

LifeWave provides a non-invasive monitoring system that measures lung fluid to help manage heart failure at home and in clinic. The company combines a medical radar lung sensor built on ultra-wideband radio frequency (UWB/RF) with an AI-powered CardioConnect platform to deliver an objective biomarker for lung fluid and support Guideline Directed Medical Therapy (GDMT) optimization. CardioConnect is offered as a SaaS solution that integrates clinician workflows and patient self-management, and the sensing hardware is intended for simple, low-cost home use. LifeWave holds issued and pending patents around its UWB/RF physiologic assessment technology and targets homecare programs, clinicians, and heart failure patients.